文献速递中医内科中药与中成药合理使用针灸推拿

中医药在放射性肠病中的作用与治疗应用研究进展

Research progress on the role and therapeutic applications of traditional Chinese medicine in radiation enteropathy.
PubMed 文献 · Front Pharmacol · 2026-03-31

放射性肠病是放疗后难治性并发症,治疗选择有限。本综述系统汇总中药复方(如加味白头翁汤、西黄丸、TJ-14)与针灸治疗放射性肠病的证据,提示其具有抗炎、抗氧化、调节凋亡与增殖、修复肠屏障及调节肠道菌群等多重机制。临床研究报道症状改善与炎症标志物下降,临床前模型显示对放射性肠损伤有保护作用,但现有证据受方法学局限制约,存在显著转化差距。

要点

  • 中药复方与针灸可能通过抗炎、抗氧化、修复肠屏障等多靶点机制改善放射性肠病。
  • 临床研究报道症状改善与炎症标志物下降,但样本量小且多缺乏严格随机对照。
  • 机制研究因果推断有限,需采用CRISPR菌群编辑、PK-PD建模及贝叶斯自适应试验等创新设计。

核心结论

  • 中医药复方与针灸作为放射性肠病的补充干预具有多机制潜力,但现有证据受方法学局限制约,尚需严谨研究明确其在整合治疗策略中的定位。

研究设计与样本

  • 本综述系统汇总中药复方(如加味白头翁汤、西黄丸、TJ-14)与针灸治疗放射性肠病的现有研究证据。

主要发现

  • 现有研究提示抗炎、抗氧化、调节凋亡与增殖、恢复肠屏障完整性及调节肠道菌群等多重作用机制。
  • 临床研究报道症状改善与炎症标志物下降,临床前模型显示对放射性肠损伤有保护作用。

临床怎么用

  • 可将中药复方与针灸视为放射性肠病的潜在补充干预,但需结合方法学质量谨慎解读现有证据。

局限性

  • 许多临床研究样本量小且缺乏严格设计(如无随机对照)。
  • 机制研究因果推断有限,且依赖临床相关性存疑的模型,导致显著转化差距。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiation enteropathy (RE) is a debilitating complication following radiotherapy, with currently limited treatment options. Multi-target intervention strategies such as Traditional Chinese Medicine (TCM) botanical formulas and acupuncture have been investigated as potential complementary approaches for its management. This review systematically synthesizes the evidence on TCM botanical formulas (e.g., Modified Baitouweng Decoction, Xihuang Pill, TJ-14) and acupuncture for the treatment of RE. Existing studies suggest multiple mechanisms of action, including anti-inflammatory and antioxidant effects, regulation of apoptosis and proliferation, restoration of intestinal barrier integrity, and modulation of gut microbiota. Clinical studies have reported improvements in symptoms and reductions in inflammatory markers, while preclinical models have demonstrated protective effects against radiation-induced intestinal injury. However, the current body of evidence is generally constrained by methodological limitations. Many clinical studies have small sample sizes and lack rigorous designs (e.g., absence of randomized controls), while mechanistic research often provides limited causal inference and relies on models with questionable clinical relevance, resulting in a significant translational gap. Based on this appraisal, we critically evaluate the limitations of existing research and propose future directions. These include: (i) employing CRISPR-based microbiome editing to investigate causal mechanisms; (ii) developing pharmacokinetic-pharmacodynamic (PK-PD) models for dose individualization; and (iii) utilizing innovative trial designs such as Bayesian adaptive trials to bridge the gap between empirical practice and evidence-based medicine. Rigorous further investigation is essential to define the role of these TCM interventions within the integrative treatment strategy for RE.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Liang Y, Chen H, Ren G, et al. Research progress on the role and therapeutic applications of traditional Chinese medicine in radiation enteropathy. Front Pharmacol. 2026. PMID: 41988516. doi:10.3389/fphar.2026.1747735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。